Fabio
4.3 KiB
4.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. | Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. | us/states/tn | Tennessee General Assembly | 114 | SB 48 | Tennessee SB 48 (114) |
|
|
enacted |
|
3 | 20 | 3 | 2025-01-09 | 2025-05-13 | openstates | ocd-bill/e209194b-4732-41b5-95c0-4113e9c23918 | https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=SB0048&ga=114 | 7a9df863565ab20df48d7281458dc43f6525a5151cd516cceaed377c050bba28 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee SB 48 (114) — Opioids - As enacted, adds Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries, Inc., Indivior Inc., Viatris Inc., and Purdue Pharma L.P. to the list of companies that may be released by the attorney general and reporter for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Amendment HA0377 (committee substitute) — source
- Amendment SA0041 (committee substitute) — source
- Current Version (committee substitute) — source
Votes
- SENATE JUDICIARY COMMITTEE: Recommended for passage with amdt, refer to Senate Calendar Committee 3/4/2025 Passed — 9–0 (pass) · upper
- FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/16/2025 Passed — 91–0 (pass) · lower
- FLOOR VOTE: as Amended Third Consideration 3/10/2025 Passed — 29–0 (pass) · upper
Sponsors
- Haile — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-01-09 Filed for introduction
filing - 2025-01-14 Introduced, Passed on First Consideration
introduction - 2025-01-15 Passed on Second Consideration, refer to Senate Judiciary Committee
referral-committee - 2025-02-26 Placed on Senate Judiciary Committee calendar for 3/4/2025
- 2025-03-04 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays0 PNV 0
- 2025-03-07 Placed on Senate Regular Calendar for 3/10/2025
- 2025-03-10 Engrossed; ready for transmission to House
receipt - 2025-03-10 Passed Senate as amended, Ayes 29, Nays 0, PNV 1
passage - 2025-03-10 Senate adopted Amendment (Amendment 1 - SA0041)
- 2025-03-13 Rcvd. from S., held on H. desk.
- 2025-04-16 Passed H., Ayes 91, Nays 0, PNV 1
passage - 2025-04-16 Am. withdrawn. (Amendment 1 - HA0377)
amendment-withdrawal - 2025-04-16 Subst. for comp. HB.
substitution - 2025-04-21 Signed by H. Speaker
passage - 2025-04-21 Signed by Senate Speaker
passage - 2025-04-21 Enrolled and ready for signatures
enrolled - 2025-04-22 Transmitted to Governor for action.
executive-receipt - 2025-05-02 Signed by Governor.
executive-signature - 2025-05-13 Effective date(s) 05/02/2025
- 2025-05-13 Pub. Ch. 302
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/e209194b-4732-41b5-95c0-4113e9c23918. Confidence: reported (aggregated from official Tennessee legislature records).